The ligands of CXCR3 are CXC-chemokine ligand 9 (CXCL9) and CXCL10, whose elevated levels are related with enhanced amounts of tumor-infiltrating CD8+ T cells, subsequently decreased cancer metastasis and improved survival rates of colon cancer and ovarian cancer patients. Here, CD8A is linked to neoplasm.